Manitol Infomed Fluids

Mannitol, the active ingredient in Manitol Infomed Fluids, is an osmotic diuretic presented as an intravenous solution for intravenous use. It is employed to lower intracranial pressure and to stimulate urine output in patients with renal failure or fluid overload. The product conforms to European Union pharmaceutical standards and is supplied in a sterile, preservative‑free formulation suitable for hospital infusion sets.

GNH USA supplies Manitol Infomed Fluids as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Mannitol acts as an osmotic agent in conditions where fluid shifts are therapeutic. - Intracranial hypertension: reduces intracranial pressure by drawing water from brain tissue into the vascular compartment. - Oliguric renal failure: promotes diuresis to improve urine output and aid renal clearance. - Acute fluid overload: increases extracellular fluid excretion to manage edema and prevent pulmonary congestion.

Mannitol may be associated with a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate discomfort often related to rapid fluid shifts. - Nausea or vomiting: gastrointestinal upset during infusion. - Electrolyte imbalance: especially hyponatremia or hyperkalemia. - Transient hypotension: due to intravascular volume changes. - Flank pain: renal colic‑like sensation.

Serious or Rare Side Effects: - Acute renal failure: worsening kidney function in susceptible patients. - Pulmonary edema: fluid overload in patients with compromised cardiac function. - Severe electrolyte disturbances: profound hyponatremia or hyperosmolar states. - Anaphylactoid reactions: rare hypersensitivity with rash, bronchospasm, or hypotension.

Mannitol should be used with careful clinical monitoring. - Renal function: assess baseline creatinine and urine output before initiation. - Cardiovascular status: avoid in patients with severe heart failure or uncontrolled hypertension. - Fluid balance: monitor input/output charts to prevent overload. - Electrolytes: check serum sodium, potassium, and osmolality regularly. - Pregnancy: safety category unknown; use only if benefits outweigh potential risks. - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight, and retain in original sealed container.

Mannitol may alter the pharmacokinetics of several agents.

Major Interactions (Avoid): - Loop diuretics (e.g., furosemide): additive nephrotoxic risk and excessive diuresis. - Nephrotoxic antibiotics (e.g., aminoglycosides): heightened potential for renal injury.

Moderate Interactions (Monitor Closely): - Antihypertensives: may potentiate blood pressure lowering effects. - Lithium: osmotic shifts can increase serum lithium levels. - Insulin or oral hypoglycemics: osmotic diuresis may affect glucose control. - Contrast media: combined osmotic load can exacerbate renal dysfunction.